News for Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SS)

Published at

Mar 29, 2024 1:40 AM

by investing.com

mixed

mixed

InnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib By Investing.com

InnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib

688578.SS 9969.HK

Read more →